PFM Health Sciences’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.95M | Buy |
|
|||||
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $11.4M | Buy |
|
|||||
|
2024
Q4 | $2.73M | Sell |
|
|||||
|
2024
Q3 | $8.16M | Buy |
|
|||||
|
2024
Q2 | $7.95M | Sell |
|
|||||
|
2024
Q1 | $15.7M | Buy |
|
|||||
|
2023
Q4 | $12.9M | Sell |
|
|||||
|
2023
Q3 | $39.4M | Buy |
|
|||||
|
2023
Q2 | $45.5M | Buy |
|
|||||
|
2023
Q1 | $41.1M | Buy |
|
|||||
|
2022
Q4 | $46.2M | Buy |
|
|||||
|
2022
Q3 | $31M | Buy |
|
|||||
|
2022
Q2 | $11.2M | Sell |
|
|||||
|
2022
Q1 | $35.5M | Sell |
|
|||||
|
2021
Q4 | $46M | Buy |
|
|||||
|
2021
Q3 | $35.5M | Sell |
|
|||||
|
2021
Q2 | $36.8M | Buy |
|
|||||
|
2021
Q1 | $33.2M | Buy |
|